Overall Status

Completed (267)

Recruiting (66)

Not yet recruiting (61)

Unknown status (61)

Active, not recruiting (29)

Terminated (27)

Withdrawn (16)

Enrolling by invitation (3)

Phase

n/a (149)

phase 2 (128)

phase 3 (67)

phase 4 (36)

phase 1 (33)

phase 1/phase 2 (25)

early phase 1 (16)

phase 2/phase 3 (9)

Study Documents

Annotated Case Report Form (3)

Clinical Study Report (3)

Dataset Specification (3)

Individual Participant Data Set (3)

Informed Consent Form (3)

Statistical Analysis Plan (3)

Study Protocol (3)

Funder Type

Other (290)

Industry (237)

NIH (3)

Study Type

Interventional (463)

Observational (62)

Observational [Patient Registry] (5)

Alopecia Areata

Showing 526 - 530 of 530

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Alopecia Trial (MTS-01, Placebo)

Terminated

Alopecia

MTS-01
Placebo

(no location specified)

Jul 10, 2008

Androgenetic Alopecia Trial in Hamburg (tetrapeptide aldehyde proteasome inhibitor (NEOSH101))

Unknown status

Androgenetic Alopecia

tetrapeptide aldehyde proteasome inhibitor (NEOSH101)

Hamburg, Germany

bioskin Institute for Dermatological Research and Development Gm

May 16, 2008

Androgenetic Alopecia Trial in Hamburg (tetrapeptide aldehyde proteasome inhibitor (NEOSH101))

Completed

Androgenetic Alopecia

tetrapeptide aldehyde proteasome inhibitor (NEOSH101)

Hamburg, Germany

bioskin Institute for Dermatological Research and Development Gm

May 16, 2008

Alopecia Trial in Tel Aviv (AS101)

Unknown status

Alopecia

AS101

Tel Aviv, Israel

(unnamed)

Jan 3, 2007

Alopecia Areata Trial in Minneapolis (Aldara Cream 5%)

Completed

Alopecia Areata

Aldara Cream 5%

Minneapolis, Minnesota

University of Minnesota

Nov 8, 2006